Immunologically mediated photodermatoses: Diagnosis and treatment

American Journal of Clinical Dermatology

Volumn 10, Issue 3, 2009, Pages 169-180

  Gambichler, Thilo ^a   Al Muhammadi, Raida ^a   Boms, Stefanie ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Katharinen Hospital Unna   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTIOXIDANT; AVOBENZONE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLOROQUINE; CYCLOSPORIN; DROMETRIZOLE TRISILOXANE; ECAMSULE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MEXORYL SX; MEXORYL XL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYBENZONE; PARSOL; POLYPODIUM LEUCOTOMOS EXTRACT; PSORALEN; RETINOL; SUNSCREEN; TACROLIMUS; THALIDOMIDE; TITANIUM DIOXIDE; TOCOPHEROL; UNCLASSIFIED DRUG; ZINC;

ACTINIC PRURIGO; CHRONIC ACTINIC DERMATITIS; DERMATITIS; HUMAN; HYDROA VACCINIFORME; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGICALLY MEDIATED PHOTODERMATOSIS; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PHOTODERMATOSIS; PHOTOSENSITIVITY; POLYMORPHIC LIGHT ERUPTION; PRIORITY JOURNAL; REVIEW; SOLAR URTICARIA; ULTRAVIOLET RADIATION;

HUMANS; IMMUNE SYSTEM DISEASES; PATCH TESTS; PHOTOSENSITIVITY DISORDERS; PRURIGO; ULTRAVIOLET RAYS; URTICARIA;

EID: 64749107449     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200910030-00003     Document Type: Review

References (86)

1. Lim HW, Honigsmann H,Hawk JLM, editors. Photodermatology. New York: Informa Healthcare USA Inc., 2007
2. Ferguson J, Dover JS, editors. Photodermatology. London: Manson Publishing Ltd, 2006
3. Yashar SS, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7
4. Millard TP, Hawk LM. Photosensitive disorders: cause, effect, and management. Am J Clin Dermatol 2002; 3: 239-46
5. Palmer RA, Hawk JL, Young AR, et al. The effect of solar-simulated radiation on the elicitation phase of contact hypersensitivity does not differ between controls and patients with polymorphic light eruption. J Invest Dermatol 2005 Jun; 124 (6): 1308-12
6. Stratigos AJ, Antoniou C, Papathanakou E, et al. Spectrum of idiopathic photodermatoses in a Mediterranean country. IntJ Dermatol 2003; 42: 449-54
7. Holzle E. Photodermatosen. Akt Dermatol 1996; 22: 15-9
8. Sassa S. The porphyrias. Photodermatol Photoimmunol Photomed 2002; 18: 56-67
9. Meffert B, Meffert H. Optische Strahlung und ihre Wirkungen auf die Haut. Biomed Technik 2000; 45: 98-104
10. Mathes R, Sliney D, editors. Measurements of optical radiation hazards. Munich: Märkl-Druck, 1998
11. McKinlay AF, Diffey BL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE J 1987; 6: 17-22
12. Lehmann P. Diagnostic approach to photodermatoses. J Dtsch Dermatol Ges 2006; 4: 965-75
13. Roelandts R. The diagnosis of photosensitivity. Arch Dermatol 2000; 136:1152-7
14. Wolf R, Oumeish OY. Photodermatoses. Clin Dermatol 1998; 16: 41-57
15. Van de Pas CB, Hawk JL, Young AR, et al. An optimal method for experimental provocation of polymorphic light eruption. Arch Dermatol 2004; 140:286-92
16. Dummer R, Ivanova K, Scheidegger EP, et al. Clinical and therapeutical aspects of polymorphous light eruption. Dermatology 2003; 207: 93-5
17. Ling TC, Richards HL, Janssens AS, et al. Seasonal and latitudinal impact of polymorphic light eruption on quality of life. J Invest Dermatol 2006; 126: 1648-51
18. Boonstra HE, van Weelden H, Toonstra J, et al. Polymorphous light eruption: a clinical, photobiologic and follow-up study of 110 patients. J Am Acad Dermatol 2000; 42: 199-207
19. Ling TC, Gibbs NK, Rhodes LE. Treatment of polymorphic light eruption. Photodermatol Photoimmunol Photomed 2003; 19: 217-27
20. Kölgen W, van Meurs M, Jongsma M, et al. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression. Arch Dermatol 2004; 140: 295-30
21. Hjorth N, Sjolin KE, Sylvest B, et al. Acne aestivalis: Mallorca acne. Acta Derm Venerol 1972; 52: 61-3
22. Verbov J. Actinic folliculitis. Br J Dermatol 1985; 113: 630-1
23. Veysey EC, George S. Actinic folliculitis. Clin Exp Dermatol 2005; 30: 659-61
24. Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, et al. Diagnosis and treatment of actinic prurigo. Dermatol Ther 2003; 16: 40-4
25. Lippert U, Schauder S, Neumann C. Aktinische Prurigo. Hautarzt 2000; 51: 597-603
26. Arrese JE, Dominguez-Soto L, Hojyo-Tomoka MT, et al. Effectors of inflammation in actinic prurigo. J Am Acad Dermatol 2001; 44: 957-61
27. Gomez A, Umana A, Trespalacios AA. Immune responses to isolated human skin antigens in actinic prurigo. Med Sci Monit 2006; 12: 106-13
28. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42: 208-13
29. Demachi A, Nagata H, Morio T, et al. Characterization of Epstein-Barr Virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions. Microbiol Immunol 2003; 47: 543-52
30. Iwatsuki K, Xu ZG, Takata M, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999; 140: 715-21
31. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142: 587-95
32. Hawk JLM. Chronic actinic dermatitis. Photodermatol Photoimmunol Photomed 2004; 20: 312-4
33. Yap LM, Foley P, Crouch R, et al. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology unit. Australas J Dermatol 2003; 44: 256-62
34. Menage Hdu P, Sattar NK, Haskard DO, et al. A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis. Br J Dermatol 1996; 134: 262-8
35. Chu AC, Robinson D, Hawk JL, et al. Immunologic differentiation of the Sezary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis. J Invest Dermatol 1986; 86: 134-7
36. Bakels V, van Oostveen JW, Preesman AH, et al. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J Clin Pathol 1998; 51: 154-8
37. Bilsland D, Crombie IK, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome: no association with lymphoreticular malignancy. Br J Dermatol 1994; 131: 209-14
38. Schauder S. Solar urticaria [in German]. Hautarzt 2003; 54: 952-8
39. Sams Jr WM. Solar urticaria: studies of the active serum factor. J Allerg 1970; 45: 295-301
40. Kojma M, Horiko T, Nakamara Y, et al. Solar urticaria: relationship of photoallergen and action spectrum. Arch Dermatol 1986; 122: 550-5
41. Leenutapong V, Hölzle E, Plewig G. Solar urticaria: studies on the mechanisms of tolerance. Br J Dermatol 1990; 122: 601-6
42. Fukunaga A, Horikawa T, Yamamoto A, et al. The inhibition spectrum of solar urticaria suppresses the wheal-flare response following intradermal injection with photo-activated autologous serum but not with compound 48/80. Photodermatol Photoimmunol Photomed 2006; 22: 129-32
43. Das S, Lloyd JJ, Walshaw D, et al. Provocation testing in polymorphic light eruption using fluorescent ultraviolet (UV) A and UVB lamps. Br J Dermatol 2004; 151: 1066-70
44. Neumann NJ, Fritsch C, LehmannP.Photodiagnostische Testverfahren Teil 1. Hautarzt 2000; 51: 113-25
45. Fitzpatrick TB. The validity and practicality of sun-ractive skin types I and IV. Arch Dermatol 1988; 124: 869-87
46. Beattie PE, Dawe RS, Ferguson J, et al. Dose-response and time-course characteristics of UV-A1 erythema. Arch Dermatol 2005; 141: 1549-55
47. Gambichler T, Moussa G, Tomi NS, et al. Reference limits for erythema effective ultraviolet doses. Photochem Photobiol 2006; 82: 1097-102
48. Murphy GM. Investigation of photosensitive disorders. Photodermatol Photoimmunol Photomed 2004; 20: 305-11
49. Bruynzeel DP, Ferguson J, Andersen K, et al. Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 2004; 18:679-82
50. Gambichler T, Breuckmann F, Boms S, et al. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 2005; 52: 660-70
51. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132:956-63
52. Jeanmougin M, Peyron JL, Thomas P, et al. Polymorphic light eruption: prophylaxis using a topical combination of antioxidants and UVA protection formulations. Ann Dermatol Venereol 2006; 133: 425-8
53. Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 2000; 42: 1030-2
54. Uetsu N, Okamoto H, Fujii K, et al. Treatment of chronic actinic dermatitis with tacrolimus. J Am Acad Dermatol 2002; 47: 881-4
55. Edstrom DW, Ros AM. Cyclosporin A therapy for severe solar urticaria. Photodermatol Photoimmunol Photomed 1997; 13: 61-3
56. Mang R, Stege H, Budde MA, et al. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis): a case report. Photodermatol Photoimmunol Photomed 2002; 18: 196-8
57. Collins P, Ahamat R, Green C, et al. Plasma exchange therapy for solar urticaria. Br J Dermatol 1996; 134: 1093-7
58. Evans AV, Palmer RA, Hawk JL. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed 2004; 20: 59-61
59. Calnan CD, Meara RH. Actinic prurigo (Hutchinson's summer prurigo). Clin Exp Dermatol 1977; 2: 365-72
60. Wu JJ, Huang DB, Pang KR, et al. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol 2005; 153: 254-73
61. Duschet P, Leyen P, Schwarz T, et al. Solar urticaria: effective treatment by plasmapheresis. Clin Exp Dermatol 1987; 12: 185-7
62. Gambichler T, Laperre J, Hoffmann K. The European standard for sun-protective clothing: EN 13758. J Eur Acad Dermatol Venereol 2006; 20: 125-30
63. Hampton PJ, Farr PM, Diffey BL, et al. Implication for photosensitive patients of ultraviolet A exposure in vehicles. Br J Dermatol 2004; 151: 873-6
64. Gambichler T, Altmeyer P, Hoffmann K. Role of clothes in sun protection. Recent Results Cancer Res 2002; 160: 15-25
65. Gambichler T, Laperre J, Altmeyer P, et al. UVA and UVB transmission of fabrics: critical wavelength based on absorbance and effective dose. Exog Dermatol 2002; 1: 290-5
66. Peyron JL, Raison-Peyron N, Meynadier J, et al. Prevention of solar urticaria using a broadspectrum sunscreen and determination of a solar urticaria protection factor (SUP). In: Rougier A, Schaefer H, editors. Protection of the skin against ultraviolet radiation. Paris: John-Libbey Eurotext, 1998:201-5
67. Van den Keybus C, Laperre J, Roelandts R. Protection from visible light by commonly used textiles is not predicted by ultraviolet protection. J Am Acad Dermatol 2006; 54: 86-93
68. Schauder S, Schrader A, Ippen H. Göttinger Liste: Sonnenschutzkosmetik in Deutschland: 4. Neubearbeitete und erweiterte Auflage. Berlin-Wien: Blackwell Wissenschafts-Verlag, 1996
69. Tuchinda C, Lim HW, Osterwalder U, et al. Novel emerging sunscreen technologies. Dermatol Clin 2006; 24: 105-17
70. Honigsmann H. Mechanisms of phototherapy and photochemotherapy for photodermatoses. Dermatol Ther 2003; 16: 23-7
71. Janssens AS, Pavel S, Out-Luiting JJ, et al. Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption. Br J Dermatol 2005; 152: 1268-74
72. Darras S, Segard M, Mortier L, et al. Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy. Ann Dermatol Venerol 2004; 131: 65-9
73. Caccialanza M, Percivalle S, Piccinno R, et al. Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses. Photodermatol Photoimmunol Photomed 2007; 23: 46-7
74. Patel DC, Bellaney GJ, Seed PT, et al. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomised controlled trial. Br J Dermatol 2000; 142: 112-4
75. Londono F. Thalidomide in the treatment of actinic prurigo. Int J Dermatol 1973; 12: 326-8
76. Batto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol 2008; 59: 909-20
77. Puech-Plottova I, Michel JL, Rouchhouse JL, et al. Solar urticaria: one case treated by intravenous globulin. Ann Dermatol Venereol 2000; 127: 831-5
78. Bartunkova J, Kayserova J, Shoenfeld Y. Allergy and autoimmunity: parallels and dissimilarity: the yin and yang of immunopathology. Autoimmun Rev 2009; 8: 302-8
79. Honigsmann H. Polymorphous light eruption. Photodermatol Photoimmunol Photomed 2008; 24: 155-61
80. Ross G, Foley P, Baker C. Actinic prurigo. Photodermatol Photoimmunol Photomed 2008; 24: 272-5
81. Tzaneva S, Volc-Platzer B, Kittler H, et al. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study. Br J Dermatol 2008; 158: 1050-4
82. 105 against polymorphic light eruption. J Invest Dermatol 2008; 128: 1901-5
83. Güzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008; 63: 1563-5
84. Pareek A, Khopkar U, Sacchidanand S, et al. Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study. Indian J Dermatol Venereol Leprol 2008; 74: 18-22
85. Richards HL, Ling TC, Evangelou G, et al. Evidence of high levels of anxiety and depression in polymorphic light eruption and their association with clinical and demographic variables. Br J Dermatol 2008; 159: 439-44
86. Jong CT, Finlay AY, Pearse AD, et al. The quality of life of 790 patients with photodermatoses. Br J Dermatol 2008; 159: 192-7